Methodological Challenges in Biomedical HIV Prevention Trials (2008)

Chapter: 2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF.

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: 1 The Status and Challenges of Biomedical HIV Prevention Trials
Page 69 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 69
Page 70 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 70
Page 71 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 71
Page 72 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 72
Page 73 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 73
Page 74 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 74
Page 75 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 75
Page 76 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 76
Page 77 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 77
Page 78 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 78
Page 79 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 79
Page 80 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 80
Page 81 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 81
Page 82 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 82
Page 83 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 83
Page 84 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 84
Page 85 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 85
Page 86 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 86
Page 87 Cite Bookmark
Suggested Citation: "2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Save
Cancel
Page 87
Next Chapter: 3 Design Considerations: Risk-Reduction Counseling
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.